Biotech Values

[ghmm]

DDXS / GSK / darapladib:

I finally took a (smaller) real life position (I picked them in my SI charity portfolio) in DDXS. I am debating how big to make because they do have some issues (IP, darapladib). From a financial standpoint the company is very cheap valuing them on multiple of sales especially factoring in growth rate.

I recall jq (I believe) posting some negative thoughts on the odds of success for darapladib. I looked a little at the Phase 2 and it seems they rushed into Phase 3. I'm curious if anyone else has an opinion on darapladib and thoughts on its likely of success or failure.

I am a bit behind on why people follow the Baker brothers but they have a big stake (13.4%) and those whole like exercise early and hold the CEO and CBO both did but its not huge amounts and think it may be their initial positions.